AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34786992 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone
Number of subjects: 55
Study 34786992 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 55
Study 34786992 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone plus Lidocaine
Number of subjects: 55
Study 34786992 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 55
Study 32112909 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free dentifrice (nHA0)
Number of subjects: 20
Study 32112909 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm F- dentifrice (NaF0)
Number of subjects: 20
Study 32112909 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 ppm F- as NaF (NaF1100)
Number of subjects: 20
Study 32112909 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 ppm F- as NaF (NaF5000)
Number of subjects: 20
Study 34213691 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 t/ha MSWC
Number of subjects: 0
Study 34213691 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 t/ha MSWC
Number of subjects: 0
Study 34213691 — intervention group
Group type: COMPARATOR
Intervention: 0 t/ha MSWC (unamended, control)
Number of subjects: 0
Study 32594854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 985 mg/d)
Number of subjects: 15
Study 32594854 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 0.37 mg/d)
Number of subjects: 15
Study 32738298 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample pooling approach for wide-scale population screening for COVID-19
Number of subjects: 940
Study 32738298 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated RNA extraction followed by RT-PCR
Number of subjects: 940
Study 35599701 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation (enoxaparin or unfractionated heparins)
Number of subjects: 159
Study 35599701 — intervention group
Group type: COMPARATOR
Intervention: Low-dose anticoagulation in acutely ill participants/intermediate-dose anticoagulation in critically ill participants
Number of subjects: 159
Study 35599701 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 159
Study 35599701 — intervention group
Group type: COMPARATOR
Intervention: Low/intermediate anticoagulation
Number of subjects: 159
Study 34499665 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 473
Study 34499665 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV screening
Number of subjects: 473
Study 34499665 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-TB screening
Number of subjects: 473
Study 35639970 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT)
Number of subjects: 1390
Study 35639970 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1390
Study 35639970 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT) in SCC subgroup
Number of subjects: 1390
Study 35639970 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone in SCC subgroup
Number of subjects: 1390
Study 35639970 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT) in AC subgroup
Number of subjects: 1390
Study 35639970 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone in AC subgroup
Number of subjects: 1390
Study 34134434 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic waste exposure (Lead exposure)
Number of subjects: 187
Study 34134434 — intervention group
Group type: COMPARATOR
Intervention: Referent group (no electronic waste exposure)
Number of subjects: 187
Study 32359267 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype violins made from fiber-reinforced polymers
Number of subjects: 0
Study 32359267 — intervention group
Group type: COMPARATOR
Intervention: Control group of traditional wooden violins (implied)
Number of subjects: 0
Study 36241477 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0
Study 36241477 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study 33651090 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinatumomab (2 cycles)
Number of subjects: 208
Study 33651090 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (2 cycles)
Number of subjects: 208
Study 32285242 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching support for implementation of evidence-based programs (EBPs)
Number of subjects: 40
Study 616518461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5mg once daily
Number of subjects: 40
Study 616518461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35305746 — intervention group
Group type: EXPERIMENTAL
Intervention: PACT-G
Number of subjects: 249
Study 35305746 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 249
Study 32750250 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide at a dose of 1.8 mg/d
Number of subjects: 0
Study 32750250 — intervention group
Group type: COMPARATOR
Intervention: Orlistat, phentermine/topiramate, naltrexone/bupropion
Number of subjects: 0
Study 36227352 — intervention group
Group type: EXPERIMENTAL
Intervention: THC-dominant cannabis (13.75 mg THC)
Number of subjects: 26
Study 36227352 — intervention group
Group type: EXPERIMENTAL
Intervention: THC/CBD-equivalent cannabis (13.75 mg THC/13.75 mg CBD)
Number of subjects: 26
Study 36227352 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD-dominant cannabis (13.75 mg CBD)
Number of subjects: 26
Study 36227352 — intervention group
Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 26
Study 34155720 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain educational video intervention
Number of subjects: 89
Study 34155720 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no video)
Number of subjects: 89
Study 32577708 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual eyeglasses
Number of subjects: 30
Study 32577708 — intervention group
Group type: COMPARATOR
Intervention: Control (eyes covered)
Number of subjects: 30
Study 35737735 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologically based cord clamping (PBCC)
Number of subjects: 123
Study 35737735 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 123
Study 35737735 — intervention group
Group type: EXPERIMENTAL
Intervention: PBCC
Number of subjects: 123
Study 35737735 — intervention group
Group type: COMPARATOR
Intervention: ECC
Number of subjects: 123
Study 33788464 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment at Dahe (KI 12), Zhongzhu (KI 15), Hegu (LI 4), Xuehai (SP 10) for 30 min, once a day, for 2 courses with 1-day interval.
Number of subjects: 80
Study 33788464 — intervention group
Group type: COMPARATOR
Intervention: Oral Xinshenghua tablet, 4 tablets each time, 3 times a day for 7 days.
Number of subjects: 80
Study 33788464 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment
Number of subjects: 80
Study 35038310 — intervention group
Group type: EXPERIMENTAL
Intervention: New care organization intervention involving case management, liaising with pediatric services, personalizing care pathways, and liaising with external structures.
Number of subjects: 202
Study 35038310 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients transferred during the control period 04/2014-08/2016).
Number of subjects: 202
Study 34464237 — intervention group
Group type: EXPERIMENTAL
Intervention: Pes-guided PEEP
Number of subjects: 200
Study 34464237 — intervention group
Group type: COMPARATOR
Intervention: Empirical high PEEP
Number of subjects: 200
Study 34464237 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP titrated to end-expiratory transpulmonary pressure near 0 cm H2O
Number of subjects: 200
Study 34318633 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid 0.5 g dissolved in 20 ml normal saline injected into femoral bone marrow cavity for local treatment
Number of subjects: 100
Study 34318633 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid 20 minutes before operation, 15 mg/kg diluted in 250 ml sodium chloride injection, intravenous drip
Number of subjects: 100
Study 32345916 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal CBD (20 mg/day)
Number of subjects: 0
Study 32345916 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonliposomal CBD (50 mg/day)
Number of subjects: 0
Study 32345916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32631081 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 41
Study 32631081 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injection (MDI)
Number of subjects: 41
Study 32631081 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study 35236397 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal psychoeducation (safeTALK) and screening for suicide risk
Number of subjects: 0
Study 35236397 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioural Therapy (Reframe IT) for high-risk students
Number of subjects: 0
Study 35236397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness evaluation of the programme
Number of subjects: 0
Study 34131763 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy along with conventional management
Number of subjects: 3095
Study 34131763 — intervention group
Group type: COMPARATOR
Intervention: Conventional management only
Number of subjects: 3095
Study 36050653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab after Temozolomide
Number of subjects: 18
Study 36050653 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide (50 mg/m2 for 3 months)
Number of subjects: 18
Study 36050653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 18
Study 33840806 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional video on NSICU nursing skills
Number of subjects: 70
Study 33840806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video instruction)
Number of subjects: 70
Study 616116613 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by VA stabilization
Number of subjects: 277
Study 616116613 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by disease activity
Number of subjects: 277
Study 616116613 — intervention group
Group type: COMPARATOR
Intervention: Verteporfin photodynamic therapy (vPDT)
Number of subjects: 277
Study 35083559 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel balloon catheter dilation therapy
Number of subjects: 34
Study 35083559 — intervention group
Group type: COMPARATOR
Intervention: 14-Fr ordinary urinary catheter dilation therapy
Number of subjects: 34
Study 33460579 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin (hs-cTn) using the female-specific 99th percentile threshold
Number of subjects: 2073849
Study 33460579 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (not explicitly defined)
Number of subjects: 2073849
Study 32819352 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional written feedback on patient satisfaction combined with guided self-reflection
Number of subjects: 71
Study 32819352 — intervention group
Group type: COMPARATOR
Intervention: Usual immediate formative multisource feedback from tutors, patients, and peers
Number of subjects: 71
Study 35960119 — intervention group
Group type: EXPERIMENTAL
Intervention: Schumann resonance (SR) device + oxybutynin for 12 weeks
Number of subjects: 35
Study 35960119 — intervention group
Group type: COMPARATOR
Intervention: Active-control group (oxybutynin only)
Number of subjects: 35
Study 33787926 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 105
Study 33787926 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Therapy (SBT)
Number of subjects: 105
Study 32349117 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/d oral tropisetron
Number of subjects: 40
Study 32349117 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/d oral tropisetron
Number of subjects: 40
Study 32349117 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d oral tropisetron
Number of subjects: 40
Study 32349117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34758408 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared technology (AccuVein AV-500®) for PIVC
Number of subjects: 0
Study 34758408 — intervention group
Group type: COMPARATOR
Intervention: Standard teaching method for PIVC
Number of subjects: 0
Study 34758408 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of PIVC skill scores between groups
Number of subjects: 0
Study 34758408 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (Infrared technology and Standard teaching)
Number of subjects: 0
Study 32590958 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated clinic-community child obesity intervention
Number of subjects: 270
Study 32590958 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study 35657762 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-type O blood
Number of subjects: 544
Study 35657762 — intervention group
Group type: COMPARATOR
Intervention: Type O blood
Number of subjects: 544
Study 33162246 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral bulking agent injection
Number of subjects: 0
Study 33162246 — intervention group
Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 0
Study 33151955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (low energy diet, exercise training, optimized treatment of hypertension, dyslipidemia, and diabetes)
Number of subjects: 62
Study 33151955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 62
Study 33151955 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 62
Study 35158086 — intervention group
Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND)
Number of subjects: 50
Study 35158086 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 33932226 — intervention group
Group type: EXPERIMENTAL
Intervention: Montessori classrooms (adapted to French public education)
Number of subjects: 176
Study 33932226 — intervention group
Group type: COMPARATOR
Intervention: Conventional classrooms
Number of subjects: 176
Study 35452414 — intervention group
Group type: EXPERIMENTAL
Intervention: Trust in Nurses (TN) intervention group, n = 46
Number of subjects: 92
Study 35452414 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing control group, n = 46
Number of subjects: 92
Study 34886393 — intervention group
Group type: EXPERIMENTAL
Intervention: high-sugar/low-fiber (HSLF) meals
Number of subjects: 87
Study 34886393 — intervention group
Group type: COMPARATOR
Intervention: low-sugar/high-fiber (LSHF) meals
Number of subjects: 87
Study 35331641 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib (120 mg daily for 7 days/cycle) with carboplatin and paclitaxel
Number of subjects: 595
Study 35331641 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (investigator's choice of platinum doublet chemotherapy, up to 6, 21-day cycles)
Number of subjects: 595
Study 35331641 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib + carboplatin/paclitaxel
Number of subjects: 595
Study 35331641 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 595
Study 33059763 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video clip
Number of subjects: 107
Study 33059763 — intervention group
Group type: COMPARATOR
Intervention: Participant information sheet
Number of subjects: 107
Study 36481298 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin (n=113)
Number of subjects: 233
Study 36481298 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride (n=120)
Number of subjects: 233
Study 33009052 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing (DB)
Number of subjects: 23
Study 33009052 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial Diaphragmatic Breathing (DB)
Number of subjects: 23
Study 33234658 — intervention group
Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 900
Study 33234658 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV)
Number of subjects: 900
Study 35713846 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical exercise (3 sessions per week for 16 weeks)
Number of subjects: 36
Study 35713846 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 34380392 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone
Number of subjects: 20
Study 34380392 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg triamcinolone
Number of subjects: 20
Study 32657261 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher uric acid level in patients with normal renal function
Number of subjects: 3284
Study 32657261 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher uric acid level in patients with abnormal renal function
Number of subjects: 3284
Study 32657261 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal renal function
Number of subjects: 3284
Study 35876018 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase treatment (IVT) followed by endovascular treatment (EVT)
Number of subjects: 473
Study 35876018 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) alone
Number of subjects: 473
Study 35876018 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent retriever with or without IVT
Number of subjects: 473
Study 35876018 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful reperfusion
Number of subjects: 473
Study 33288685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin (LPS) injection
Number of subjects: 10
Study 33288685 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS treatment in mice
Number of subjects: 10
Study 33288685 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil depletion and multiplexed vascular proteomics
Number of subjects: 10
Study 33288685 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS-injected mice
Number of subjects: 10
Study 32843515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral pudendal nerve block (PNB) with 0.25% ropivacaine 10 mL
Number of subjects: 72
Study 32843515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral pudendal nerve block (PNB)
Number of subjects: 72
Study 32843515 — intervention group
Group type: COMPARATOR
Intervention: Control group with 10 mL saline
Number of subjects: 72
Study 35093510 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus Emblica (Amla)
Number of subjects: 61
Study 35093510 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 34295981 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg)
Number of subjects: 90
Study 34295981 — intervention group
Group type: COMPARATOR
Intervention: Placebo (140 mg)
Number of subjects: 90
Study 34866362 — intervention group
Group type: EXPERIMENTAL
Intervention: Six lncRNA-based signature
Number of subjects: 0
Study 34065380 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated Fatty Acids (SFA)
Number of subjects: 13
Study 34065380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mono-Unsaturated Fatty Acids (MUFA)
Number of subjects: 13
Study 34065380 — intervention group
Group type: COMPARATOR
Intervention: Medium-Chain Fatty Acids (MCFA)
Number of subjects: 13
Study 32632078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program (12 weeks duration)
Number of subjects: 52
Study 32632078 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 34491371 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 12
Study 34491371 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D deficiency or insufficiency
Number of subjects: 12
Study 34491371 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D intake
Number of subjects: 12
Study 32556768 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (80 mg/day intravenously for 3 days followed by 40 mg/day orally for 4 weeks)
Number of subjects: 20
Study 32556768 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 20
Study 35838130 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Needlescopic Enucleation of the prostate (BNEP)
Number of subjects: 214
Study 35838130 — intervention group
Group type: COMPARATOR
Intervention: Bipolar Vapoenucleation of the prostate (BVEP)
Number of subjects: 214
Study 34297677 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Breaks Program (20 periods of weekly ABs, 5-10 minutes, 3-5 times a day for 17 weeks)
Number of subjects: 166
Study 34297677 — intervention group
Group type: COMPARATOR
Intervention: Control group (no active breaks)
Number of subjects: 166
Study 36102762 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior Chef programme (SC group) - 8-week nutrition education and cooking class (3 hours weekly)
Number of subjects: 468
Study 36102762 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady As You Go programme (SAYGO group) - 10-week strength and balance exercise programme (1 hour weekly)
Number of subjects: 468
Study 36102762 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SC and SAYGO intervention (combined group) - 10-week programme combining both interventions
Number of subjects: 468
Study 36102762 — intervention group
Group type: COMPARATOR
Intervention: Social programme (control group) - 10-week seated group socialising activity (once a week)
Number of subjects: 468
Study 33577011 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti‐β2 glycoprotein I antibody IgA/G/M
Number of subjects: 60
Study 33577011 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet aggregation rate
Number of subjects: 60
Study 33577011 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma fibrinogen
Number of subjects: 60
Study 33577011 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐dimer levels
Number of subjects: 60
Study 33577011 — intervention group
Group type: COMPARATOR
Intervention: Control group (33 healthy pregnant women)
Number of subjects: 60